We are live on ! Find out more
MG

Michael Gelband ExodusPoint Capital Management

AUM $15.5B
1-Year Est. Return 38.81%
 

Michael Gelband is a co-founder of ExodusPoint Capital Management, a multi-strategy hedge fund launched by veterans of larger alternative platforms. The firm pursues diversified strategies across asset classes with a focus on risk-managed absolute returns. Gelband’s firm is followed as part of the newer generation of multi-strategy complexes.

This Fund
S&P 500
This Quarter Est. Return
+7.87%
1 Year Est. Return
+38.81%
3 Year Est. Return
+110.53%
5 Year Est. Return
+124.16%
10 Year Est. Return
–
AUM
$9.04B
AUM Growth
+$2.19B
Cap. Flow
+$1.88B
Cap. Flow %
20.78%
Top 10 Hldgs %
34.88%
Holding
3,092
New
1,032
Increased
581
Reduced
587
Closed
820

Top Buys

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$435M
2
AMZN icon
Amazon
AMZN
+$334M
3
MRNA icon
Moderna
MRNA
+$53.9M
4
LIN icon
Linde
LIN
+$44.2M
5
DTE icon
DTE Energy
DTE
+$43.5M

Top Sells

Rank Stock Value
1
IWD icon
iShares Russell 1000 Value ETF
IWD
+$63.6M
2
CMCSA icon
Comcast
CMCSA
+$39.7M
3
EVRG icon
Evergy
EVRG
+$38.5M
4
PEG icon
Public Service Enterprise Group
PEG
+$38.4M
5
TECH icon
Bio-Techne
TECH
+$30.9M

Sector Composition

Rank Sector Weight
1 Technology 15.37%
2 Consumer Discretionary 10.36%
3 Financials 7.14%
4 Industrials 6.8%
5 Healthcare 6.46%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
IJR icon
2201
iShares Core S&P Small-Cap ETF
IJR
$110B
$62K ﹤0.01%
+553
New +$61.7K
LQDA icon
2202
Liquidia Corp
LQDA
$6.33B
$62K ﹤0.01%
+21,741
New +$60.2K
III icon
2203
Information Services Group
III
$241M
$61K ﹤0.01%
+10,445
New +$54.1K
OSG
2204
DELISTED
Overseas Shipholding Group Inc.
OSG
$60K ﹤0.01%
+28,757
New +$64.8K
SRGA
2205
DELISTED
Surgalign Holdings, Inc. Common Stock
SRGA
$60K ﹤0.01%
+1,445
New +$74K
QADB
2206
DELISTED
QAD Inc. Class B
QADB
$60K ﹤0.01%
+700
New +$36.6K
STEX
2207
Streamex Corp
STEX
$85M
$59K ﹤0.01%
+1,523
New +$56.9K
IBIO icon
2208
iBio
IBIO
$73M
$58K ﹤0.01%
+77
New +$56.2K
XNET
2209
Xunlei
XNET
$320M
$57K ﹤0.01%
12,500
-9,700
-44% -$49.6K
SAN icon
2210
Banco Santander
SAN
$213B
$56K ﹤0.01%
+14,230
New +$55.2K
IYH icon
2211
iShares US Healthcare ETF
IYH
$3.84B
$55K ﹤0.01%
+1,000
New +$52.9K
PANL icon
2212
Pangaea Logistics
PANL
$543M
$54K ﹤0.01%
+10,703
New +$41.5K
CNCE
2213
DELISTED
Concert Pharmaceuticals, Inc.
CNCE
$54K ﹤0.01%
+12,772
New +$54.1K
AQST icon
2214
Aquestive Therapeutics
AQST
$628M
$53K ﹤0.01%
+13,399
New +$53.5K
SCTL
2215
DELISTED
Societal CDMO, Inc. Common Stock
SCTL
$53K ﹤0.01%
+23,153
New +$58.8K
CBUS icon
2216
Cibus
CBUS
$128M
$52K ﹤0.01%
258
-166
-39% -$39.5K
CDTX
2217
DELISTED
Cidara Therapeutics
CDTX
$52K ﹤0.01%
+1,276
New +$54K
PVLA
2218
Palvella Therapeutics
PVLA
$2.13B
$52K ﹤0.01%
+169
New +$37.1K
BKCC
2219
DELISTED
BlackRock Capital Investment Corporation
BKCC
$52K ﹤0.01%
+13,357
New +$52.7K
AGFS
2220
DELISTED
AgroFresh Solutions Inc
AGFS
$52K ﹤0.01%
+24,981
New +$53.8K
AQMS icon
2221
Aqua Metals
AQMS
$10.1M
$50K ﹤0.01%
83
-352
-81% -$214K
XCUR icon
2222
Exicure
XCUR
$7.4M
$50K ﹤0.01%
+221
New +$57.9K
TKC icon
2223
Turkcell
TKC
$4.68B
$49K ﹤0.01%
+10,400
New +$48.9K
BCLI
2224
DELISTED
BRAINSTORM CELL THERAPUTC
BCLI
$48K ﹤0.01%
+846
New +$45.2K
CFMS
2225
DELISTED
Conformis, Inc. Common Stock
CFMS
$46K ﹤0.01%
1,590
+167
+12% +$3.94K
87 88
89
90 91

Similar funds

FGP
Freestone Grove Partners San Francisco, California $15.6B AUM 27.39% 1-Year Est. Return
MIFH
Migdal Insurance & Financial Holdings Petach Tikva, Israel $15.6B AUM 71.29% 1-Year Est. Return
GF
Gabelli Funds Rye, New York $15.7B AUM 36.4% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
Impax Asset Management Group
Impax Asset Management Group London, United Kingdom $15.4B AUM 26.43% 1-Year Est. Return
AA
Acorns Advisers Irvine, California $15.3B AUM 18.32% 1-Year Est. Return
OTPPB
Ontario Teachers' Pension Plan Board Toronto, Ontario, Canada $15.8B AUM 1.29% 1-Year Est. Return
NMIFOAC
National Mutual Insurance Federation of Agricultural Cooperatives Tokyo, Japan, Japan $15.3B AUM 24.71% 1-Year Est. Return

Michael Gelband's Q2 2021 Portfolio in Review

As of Q2 2021, Michael Gelband held 3,092 positions worth $9.04B, up 32% from $6.86B the previous quarter. Its ten largest holdings account for 35% of the portfolio.

Michael Gelband deployed $1.88B of net new capital in Q2 2021, opening 1,032 new positions and adding to 581 existing holdings. Its largest new stake was Linde: 151,692 shares worth $43.9M.

By sector, the portfolio is most concentrated in Technology at 15% of assets, up from 13% a quarter earlier, followed by Consumer Discretionary and Financials.

On the sell side, the largest reduction was iShares Russell 1000 Value ETF, an estimated $63.6M trimmed.

  • Michael Gelband's largest Q2 2021 buy was Linde: 151,692 shares worth $43.9M.
  • Michael Gelband added most to Microsoft in Q2 2021, an estimated $435M increase.
  • Michael Gelband's biggest Q2 2021 reduction was iShares Russell 1000 Value ETF, cutting an estimated $63.6M.
  • Michael Gelband fully exited Charles River Laboratories in Q2 2021, selling an estimated $27.9M.
  • Michael Gelband's ten largest holdings make up 35% of its $9.04B portfolio in Q2 2021.
  • Michael Gelband opened 1,032 new positions and closed 820 in Q2 2021.
  • Michael Gelband's portfolio value rose 32% quarter-over-quarter to $9.04B.

Based on ExodusPoint Capital Management's 13F filing for Q2 2021, filed 16 Aug 2021.